MARKET

IXHL

IXHL

Incannex Healthcare Ltd
NASDAQ
0.2880
+0.0380
+15.20%
After Hours: 0.2901 +0.0021 +0.73% 19:59 02/06 EST
OPEN
0.2617
PREV CLOSE
0.2500
HIGH
0.3000
LOW
0.2558
VOLUME
8.61M
TURNOVER
--
52 WEEK HIGH
2.250
52 WEEK LOW
0.0800
MARKET CAP
99.71M
P/E (TTM)
-0.3072
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at IXHL last week (0126-0130)?
Weekly Report · 5d ago
Psychedelic: Analyst raises Compass, Definium, GH Research price targets
TipRanks · 01/29 15:30
Incannex Healthcare Expands Advisory Board for Psilocybin Program
TipRanks · 01/29 13:36
Incannex announces additional appointments to Clinical Advisory Board
TipRanks · 01/29 13:16
Incannex Healthcare Expands Clinical Advisory Board With Three New Appointments
Reuters · 01/29 13:00
Weekly Report: what happened at IXHL last week (0119-0123)?
Weekly Report · 01/26 10:21
Psychedelic: Analyst initiates Atai Beckley with Buy rating
TipRanks · 01/22 16:35
Incannex announces formation of clinical advisory board for PSX-001 program
TipRanks · 01/22 13:21
More
About IXHL
Incannex Healthcare Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing combination medicines that target the underlying biological pathways associated with chronic conditions, including obstructive sleep apnoea, rheumatoid arthritis, and generalized anxiety disorder. Its lead clinical program, IHL-42X, is an oral fixed-dose combination of dronabinol and acetazolamide designed to target underlying mechanisms and act synergistically in the treatment of obstructive sleep apnoea. IHL-42X has completed a Phase II clinical trial. PSX-001 is a synthetic psilocybin treatment for the treatment of generalized anxiety disorder. PSX-001 has completed a Phase II clinical trial. IHL-675A is an oral fixed-dose combination of cannabidiol and hydroxychloroquine sulfate designed to act synergistically to alleviate inflammatory conditions, such as rheumatoid arthritis. IHL-675A is in a Phase II clinical development program.

Webull offers Incannex Healthcare Inc stock information, including NASDAQ: IXHL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IXHL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IXHL stock methods without spending real money on the virtual paper trading platform.